From - Diagnostic Testing & Emerging Technologies
A blood-based screening test capable of detecting multiple forms of early cancer just took one step closer to becoming a reality. A study published…
From - Diagnostic Testing & Emerging Technologies
Early results from an ongoing "basket study" show that targeted therapies may be effective strictly based on the tumor's molecular profile, and not primary tumor type…
From - Laboratory Industry Report
Among the many genetic profiling assays entering the commercial market, few have been more successful than Genomic Heath's Oncotype DX, which is now covered by most of …